Form 4: Amedisys Inc. Executive Receives Stock Awards and Disposes of Shares for Tax Obligations

Sentiment:

SEC Form 4


Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., reports the acquisition of restricted stock units and disposition of shares to cover tax liabilities.

Summary

  • On February 16, 2024, Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., was awarded 2,143 time-based Restricted Stock Units (RSUs).
  • These RSUs represent a contingent right to receive one share of Amedisys' common stock each.
  • The RSUs will vest in equal quarterly installments on February 16 of 2025, 2026, 2027, and 2028, contingent upon continuous employment with Amedisys.
  • On May 3, 2024, Ms. Guidroz disposed of 283 shares of common stock at a price of $92.08 per share.
  • This transaction was likely to cover tax obligations related to the vesting of previously granted stock awards.
  • Following these transactions, Ms. Guidroz directly owns 6,994 shares of Amedisys common stock and indirectly owns shares through a 401(k) plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and alignment of interests. There are no indications of negative performance or concerns.

Positives

  • The grant of RSUs to the Chief Accounting Officer aligns her interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.

Future Outlook

The RSUs will vest over a four-year period, contingent on continued employment.

Industry Context

Stock awards are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

  • Companies like LHC Group (now part of Optum) and Encompass Health also utilize stock-based compensation for their executives.
  • The vesting schedules and amounts of RSUs are generally comparable to industry standards for similar roles and company sizes.

Stakeholder Impact

  • The stock awards incentivize the Chief Accounting Officer to contribute to the company's success, potentially benefiting shareholders.
  • The transactions have a minimal impact on other stakeholders.

Key Dates

DateDescription
02/16/2024Grant date of 2,143 Restricted Stock Units (RSUs)
02/16/2025First vesting date for the RSUs
02/16/2026Second vesting date for the RSUs
02/16/2027Third vesting date for the RSUs
02/16/2028Final vesting date for the RSUs
05/03/2024Disposition of 283 shares of common stock
05/07/2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.